8-甲氧基芘-1,3,6-三磺酸三钠盐
8-甲氧基芘-1,3,6-三磺酸三钠盐结构式
|
常用名 | 8-甲氧基芘-1,3,6-三磺酸三钠盐 | 英文名 | 8-Methoxypyrene-1,3,6-trisulfonic acid trisodium salt |
|---|---|---|---|---|
| CAS号 | 82962-86-5 | 分子量 | 538.41200 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C17H9Na3O10S3 | 熔点 | 253-260ºC (dec.)(lit.) | |
| MSDS | 美版 | 闪点 | N/A |
|
S. Marhold et al.
Fresenius J. Anal. Chem. 336 , 111, (1990)
|
|
|
Recent advances in controlled release pulmonary therapy.
Curr. Drug Deliv. 6 , 404-414, (2009) Delivering therapeutic agents to the airways maximizes their concentration in lung tissue, decreasing systemic exposure or facilitating systemic absorption as desired. Many formulations exist for the treatment of respiratory illnesses however, no controlled r... |
|
|
Pulmonary drug delivery with aerosolizable nanoparticles in anex vivolung model
Int. J. Pharm. 367 , 169-178, (2009) The use of colloidal carrier systems for pulmonary drug delivery is an emerging field of interest in nanomedicine. The objective of this study was to compare the pulmonary absorption and distribution characteristics of the hydrophilic model drug 5(6)-carboxyf... |
|
|
Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung.
Int. J. Pharm. 351 , 158-164, (2008) For the development of aerosolized controlled release formulations such as liposomes or nanoparticles, the use of suitable model drugs is necessary. This study compared the pulmonary absorption of the three structurally diverse fluorescent markers 5(6)-carbox... |